Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

PHASE4CompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

June 28, 2007

Primary Completion Date

January 2, 2008

Study Completion Date

January 2, 2008

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG

Vyvanse (lisdexamfetamine dimesylate)

Vyvanse™ 20mg once daily at 7 a.m.; dose increased weekly by 10mg until an acceptable response is achieved. Titration may proceed to a maximum daily dose 70mg/day.

Trial Locations (46)

Unknown

Melmed Center, Scottsdale

Valley Clinical Research, El Centro

Peninsula Research Assoc, Inc, Rolling Hills Estates

UCSF-Langely Porter Psych Institute, San Francisco

Encompass Clinical Research, Spring Valley

Shire Clinical Research Site, Wildomar

Sarkis Clinical Trials, Gainesville

Shire Clinical Research Site, Hialeah

CNS Research Institute, Inc, Jacksonville

CORE Research, Inc, Maitland

Miami Research Associates, Miami

Clinical Neuroscience Solutions, Inc, Orlando

Janus Center for Psychiatric Research, West Palm Beach

Children's Development Center, Winter Park

Capstone Clinical Research, Libertyville

Indiana University School of Medicine, Indianapolis

Shire Clinical Research Site, Terre Haute

Shire Clinical Research Site, Newton

Psychiatric Associates, Overland Park

Kentucky Pediatric/Adult Research, Bardstown

Shire Clinical Research Site, Lexington

Pedia Research, Owensboro

Four Rivers Clinical Research, Inc., Paducah

Shire Clinical Research Site, Troy

University of Rochester, School of Medicine and Dentistry, Rochester

Piedmont Neuropsychiatry, Charlotte

University Commons Office Park, Durham

University Hospitals of Cleveland, Cleveland

BHI, Inc., Moore

Shire Clinical Research Site, Oklahoma City

Oregon Center for Clinical Investigations, Inc, Eugene

Oregon Center For Clinical Investigations, Inc., Portland

Summit Research Network, Portland

Oregon Center for Clinical Investigations, Inc., Salem

ADHD Program, Western Psychiatric Institute and Clinic, Pittsburgh

The Jackson Clinic, Jackson

Clinical Neuroscience Solutions, Inc, Memphis

FutureSearch Trials, Austin

Claghorn-Lesem Research Clinic Inc., Bellaire

Red Oak Psychiatry Associates P.A., Houston

R/D Clinical Research, Inc., Lake Jackson

ADHD Clinic of San Antonio, San Antonio

NeuroScience, Inc, Herndon

Dominion Clinical Research, Midlothian

International Clinical Research Associates, LLC, Richmond

Eastside Therapeutic Resource, Kirkland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY